Compare Heron Therapeutics Inc (HRTX) vs Hyperliquid Strategies Inc Common Stock (PURR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Heron Therapeutics Inc vs Hyperliquid Strategies Inc Common Stock — how do they compare? Heron Therapeutics Inc trades at $0.41 (market cap $68.01M), while Hyperliquid Strategies Inc Common Stock trades at $11.13 (market cap $2.24B). The key difference: Hyperliquid Strategies Inc Common Stock is far larger — about 32.9× Heron Therapeutics Inc's market cap, and Hyperliquid Strategies Inc Common Stock is trading nearer its 52-week high, Heron Therapeutics Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Heron Therapeutics Inc for 35 Days and Hyperliquid Strategies Inc Common Stock for 1 Days on average.
| HRTX | PURR | |
|---|---|---|
Market Cap | $68.01M | $2.24B |
Volume | 1,891,941 | 14,135,020 |
Sector | Health | Financials |
52-Week High | $1.49 | $14.09 |
52-Week Low | $0.27 | $3.10 |
Typical Hold Time | 35 Days | 1 Days |
Enterprise Value | $174.75M | $2.10B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Heron Therapeutics (HRTX) trades at $0.4061, up 4.13% today, with a bullish technical signal from moving averages. The company reported Q2 2026 revenue of $37.7M but missed EPS estimates with a $0.03 loss. Despite negative profitability metrics (-22.52% net margin), analyst consensus remains strongly positive with 89% buy ratings. Recent news highlights ongoing comparisons with peers and earnings call discussions.
HRTX faces significant fundamental challenges with consistent losses and negative ROE, though revenue stability provides some foundation. The strong analyst support suggests potential upside if operational improvements materialize, but high execution risk and cash flow concerns warrant caution for investors seeking near-term profitability.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Heron Therapeutics Inc
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →About Hyperliquid Strategies Inc Common Stock
Hyperliquid Strategies is a digital asset treasury company focused on managing a treasury of HYPE tokens, the native digital assets of the Hyperliquid Layer-1 blockchain.
Read more on PURR →
